HAMED KAMAL
SEC CIK 1946366 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | Chief Medical Off | 788.1K | — | $88.6K | 6 | 2022-09-12 | 2024-02-02 |
Most active insiders at SPRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rajavelu Esther | See Remarks | — | $406.8K |
| 2 | Keutzer Timothy | COO | — | $145.2K |
| 3 | Tregoning Kathleen | Dir | — | — |
| 4 | Zack Debra | Chief Medical Off | — | — |
| 5 | Smith Cynthia | Dir | — | — |
| 6 | Jackson Scott Thomas | Dir | — | — |
| 7 | VINK PATRICK V.J.J. | Dir | — | — |
| 8 | Deshpande Milind | Dir | — | — |
| 9 | Pottage John C Jr | Dir | — | — |
| 10 | THOMAS FRANK E | Dir | — | — |
HAMED KAMAL made no open-market trades at SPRO in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-05 | 2024-02-01 | SPRO | Spero Therapeutics, Inc. | HAMED KAMAL | Chief Medical Off | A - Grant | $0.00 | +239.7K | 816.2K | +42% | $0 | |
| 2024-02-05 | 2024-02-02 | SPRO | Spero Therapeutics, Inc. | HAMED KAMAL | Chief Medical Off | S - Sale | $1.37 | -28.1K | 788.1K | -3% | -$38.5K | |
| 2023-09-15 | 2023-09-13 | SPRO | Spero Therapeutics, Inc. | HAMED KAMAL | Chief Medical Off | S - Sale | $1.27 | -39.5K | 576.5K | -6% | -$50.2K | |
| 2023-06-14 | 2023-06-12 | SPRO | Spero Therapeutics, Inc. | HAMED KAMAL | Chief Medical Off | A - Grant | $0.00 | +140.0K | 616.0K | +29% | $0 | |
| 2023-02-03 | 2023-02-01 | SPRO | Spero Therapeutics, Inc. | HAMED KAMAL | Chief Medical Off | A - Grant | $0.00 | +266.0K | 476.0K | +127% | $0 | |
| 2022-09-14 | 2022-09-12 | SPRO | Spero Therapeutics, Inc. | HAMED KAMAL | Chief Medical Off | A - Grant | $0.00 | +210.0K | 210.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations